Drug Pricing: What Happened in 2019 and What to Watch in 2020

January 13, 2020
Thomas N. Bulleit

Have you heard that drug prices are too high? If not, you have not been listening to President Donald Trump, Secretary of Health and Human Services (“HHS”) Alex Azar, or almost any member of Congress. In the past year, a dizzying array of drug pricing actions and proposals have come out of the White House and Congress, as well as the governor’s offices and legislative halls in most states.

Click here to read the full Alert.


Thomas N. Bulleit
Thomas N. Bulleit
Retired Partner